Kestra Medical Technologies, Ltd. (KMTS) has a negative trailing P/E of -6.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -14.45%.
Criteria proven by this page:
Overall SharesGrow Score: 49/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2020 | -36.7 | 0.00 | 280.48 | 0.00 | 0.02% |
| 2021 | -31.7 | -1.87 | 612.58 | 0.00 | 0.02% |
| 2023 | -12.8 | 0.00 | -9.20 | 141.78 | 0.06% |
| 2024 | -11.5 | -0.69 | -5.17 | 38.89 | 0.07% |
| 2025 | -10.5 | -0.07 | 5.80 | 19.92 | 0.14% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2019 | $-0.59 | $0.00 | $-29.47M | - |
| 2020 | $-0.69 | $0.00 | $-34.1M | - |
| 2022 | $-1.75 | $7.63M | $-84.24M | -1104% |
| 2023 | $-2.04 | $27.81M | $-94.12M | -338.4% |
| 2025 | $-5.13 | $59.82M | $-113.81M | -190.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.34 | $-2.37 – $-2.30 | $92.97M | $92.96M – $93.79M | 4 |
| 2027 | $-2.20 | $-2.41 – $-1.94 | $132.89M | $132.74M – $133.03M | 4 |
| 2028 | $-1.77 | $-2.08 – $-1.42 | $191.14M | $191.14M – $191.14M | 6 |
| 2029 | $-1.21 | $-1.22 – $-1.19 | $268.97M | $265.12M – $271.35M | 2 |
